Taking Yasmin makes my breasts bigger

Will taking Yasmin make your breasts bigger? It is possible that taking Yasmin will make your breasts bigger. The growth and development of the breasts are affected by estrogen and estrogens, and the main ingredients of Yasmin are estrogen and estrogens, so after taking it, the breasts will become larger. It is recommended that women with breast hyperplasia should not use Yasmin for contraception or to treat menstrual disorders. It is also recommended that women have a relative breast examination before taking Yasmin to rule out the possibility of hyperplasia and other breast diseases.

When taking Yasmin, the breasts may enlarge and some may even experience swelling and pain. If this happens, you can continue taking the drug, because it is normal for such symptoms to occur within three months of taking Yasmin. It is a side effect of Yasmin. Because Yasmin is a hormonal drug, there will be a temporary fluctuation in the hormone level in the body while taking the drug.

Generally, this type of fluctuation can return to normal in two to three cycles. After three cycles, if you still feel breast enlargement or pain, you should stop taking the medicine and go to the hospital for immediate treatment. There are also some common problems when taking Yasmin. Before taking Yasmin, you need to conduct sufficient risk screening and self-assessment. Although Yasmin can be purchased at pharmacies at any time, if it is used for non-contraceptive purposes, it must be taken under the guidance of a doctor. During the period of taking Yasmin, basic routine physical examinations can be done and no special regular check-ups and follow-ups are required.

Taking Yasmin generally does not cause breast enlargement. Most women's breast growth is fully developed before the age of 20, and there is generally little growth after the age of 20. Yasmin is an emergency contraceptive. Its mechanism of action is to inhibit female ovulation. It can affect the normal function of the hypothalamic pituitary-pituitary-uterine ovarian axis, inhibit the release of GnRH by the hypothalamic pituitary, and thus reduce the secretion of follicle-stimulating hormone and progesterone by the pituitary gland. This will prevent the peak of progesterone before ovulation and make ovulation less likely. In addition, the estrogen component in emergency contraception can make the cervical mucus less regular and thicker, making it difficult for sperm to penetrate into the uterus and achieve the purpose of contraception, but it has little effect on female breasts.